Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912366 · ClinicalTrials.gov registry record
Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy
A clinical trial, sponsored by Medtronic - MITG.
- Terminated
- Registry status
- 39
- Enrollment target
NCT00912366: Clinical Trial study, sponsored by Medtronic - MITG.
NCT00912366 is a clinical trial that was terminated before completion, run by Medtronic - MITG. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00912366 was terminated before completion, sponsored by Medtronic - MITG.
- TERMINATED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Assessment of VATS versus standard open surgery for treatment of non small cell lung cancer.
Interventions
- PROCEDURE Lobectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-12 |
Why NCT00912366 stopped before completion
NCT00912366 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Lobectomy is the first listed.
NCT00912366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00912366 about?
NCT00912366 is a clinical study titled "Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy". Assessment of VATS versus standard open surgery for treatment of non small cell lung cancer.
What is the current status of trial NCT00912366?
This trial is currently terminated. The enrollment target is 39 participants. The study started on 2009-05. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00912366?
The interventions under investigation include: Lobectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00912366?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia